Artwork for podcast Pathfinders in Biopharma
The M&A Pool Set to Accelerate Biotech Innovation
Episode 23 • 3rd April 2024 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:13:51

Share Episode

Shownotes

Q1 2024 saw a handful of IPOs in the biotech sector, and mounting excitement over novel treatments. But there are less obvious trends in play, including a shift in focus by potential buyers in pharma. RBC’s biotech investment banking team analyzes deal activity in the year to date and what it signals for the sector’s future.

Follow

Links

Chapters

Video

More from YouTube